Baricitinib vs Rituximab
Baricitinib vs Rituximab: Overview
This comparison examines the pharmacological differences between Baricitinib and Rituximab.
Mechanism of Action
Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.
Rituximab: Chimeric anti-CD20 IgG1 monoclonal antibody inducing B-cell depletion via CDC, ADCC, and apoptosis.
Pharmacokinetics
Half-life: Baricitinib — 12 hours; Rituximab — 22 days.
Chemical Properties
Molecular Formula: Baricitinib — C16H17N7O2S.
Molecular Weight: Baricitinib — 371.4170 g/mol.
Type: Baricitinib — Small molecule; Rituximab — Antibody.